Lolli, Graziano
 Distribuzione geografica
Continente #
NA - Nord America 3.511
AS - Asia 1.282
EU - Europa 947
SA - Sud America 204
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 5.982
Nazione #
US - Stati Uniti d'America 3.465
SG - Singapore 639
CN - Cina 249
IT - Italia 224
RU - Federazione Russa 186
VN - Vietnam 184
BR - Brasile 171
SE - Svezia 100
GB - Regno Unito 89
DE - Germania 81
FI - Finlandia 72
FR - Francia 59
LV - Lettonia 49
KR - Corea 44
CA - Canada 29
HK - Hong Kong 27
IN - India 24
ID - Indonesia 19
BD - Bangladesh 18
NL - Olanda 17
AR - Argentina 16
IQ - Iraq 15
TR - Turchia 15
BG - Bulgaria 13
JP - Giappone 13
MX - Messico 11
UA - Ucraina 11
KE - Kenya 8
PL - Polonia 8
AT - Austria 6
ES - Italia 6
JO - Giordania 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
MA - Marocco 5
CL - Cile 4
EC - Ecuador 4
EU - Europa 4
HR - Croazia 4
VE - Venezuela 4
AU - Australia 3
LT - Lituania 3
PH - Filippine 3
SN - Senegal 3
AL - Albania 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KH - Cambogia 2
MY - Malesia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
IE - Irlanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
TW - Taiwan 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 5.982
Città #
Ashburn 398
Singapore 391
Fairfield 382
Chandler 341
Woodbridge 168
San Mateo 164
San Jose 155
Wilmington 151
Houston 139
Seattle 125
Dallas 117
Santa Clara 108
Cambridge 101
Moscow 90
Columbus 89
Princeton 85
The Dalles 59
Ann Arbor 54
Beijing 52
Trento 50
Helsinki 49
Los Angeles 49
Riga 49
Ho Chi Minh City 45
Seoul 43
Lauterbourg 41
Hanoi 38
Council Bluffs 37
Jacksonville 35
London 30
San Diego 28
Como 24
New York 24
Bremen 21
Munich 20
Orem 20
Buffalo 19
Da Nang 19
Falls Church 17
Hong Kong 17
Jakarta 17
Washington 17
Dearborn 16
Fremont 16
Sofia 13
São Paulo 13
Toronto 13
Chicago 11
Frankfurt am Main 10
Hefei 10
Shanghai 10
Montreal 9
Turku 9
Baghdad 8
Brooklyn 8
Dong Ket 8
Rome 8
Warsaw 8
Bologna 7
Hangzhou 7
Milan 7
Nanjing 7
Rio de Janeiro 7
San Paolo di Civitate 7
Tokyo 7
Amsterdam 6
Bassano del Grappa 6
Guangzhou 6
Haiphong 6
Kilburn 6
Manchester 6
Monfalcone 6
New Delhi 6
Norwalk 6
Redondo Beach 6
Riva Del Garda 6
Salt Lake City 6
Trieste 6
Wuhan 6
Boston 5
Brasília 5
Bến Tre 5
Campinas 5
Chennai 5
Denver 5
Elk Grove Village 5
Izmir 5
Nairobi 5
Phoenix 5
Stockholm 5
Altamura 4
Carapicuíba 4
Hillsboro 4
Kunming 4
Lancaster 4
Nuremberg 4
Querétaro 4
San Francisco 4
Tampa 4
Tesero 4
Totale 4.276
Nome #
Discovery of Inhibitors of Four Bromodomains by Fragment-Anchored Ligand Docking 282
Pharmacological inactivation of the prion protein by targeting a folding intermediate 232
High-Throughput Fragment Docking into the BAZ2B Bromodomain: Efficient in Silico Screening for X-Ray Crystallography 221
Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains 204
Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery 201
Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin 197
Discovery of BAZ2A bromodomain ligands 193
The "gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains 188
The STAS domain of mammalian SLC26A5 prestin harbours an anion-binding site 182
Structural characterization of the STAS domain of prestin. 171
Flavopiridol binding to P-TEFb (CDK9/cyclin T1) 165
A novel class of selective CK2 inhibitors targeting its open hinge conformation 165
Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface 165
Auto-inhibitory assembly of protein kinase CK2 revealed by X-ray crystallography. 163
Characterization of the oligomeric states of the CK2 α2β2 holoenzyme in solution 162
Derivatives of 3-Amino-2-methylpyridine as BAZ2B Bromodomain Ligands: In Silico Discovery and in Crystallo Validation 161
Structural Basis of CK2 Regulation by Autoinhibitory Oligomerization 160
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: Structural features and pharmacological potential 146
CAK—Cyclin-Dependent Activating Kinase: A Key Kinase in Cell Cycle Control and a Target for Drugs? 145
Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain 134
Pliability in the m6A-Binding Region Extends Druggability of YTH Domains 128
Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining 128
GroEL from the psychrophilic bacterium Pseudoalteromonas haloplanktis TAC 125: molecular characterization and gene cloning 124
Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight 120
Active Form of the Protein Kinase CK2 alpha(2)beta(2) holoenzyme Is a Strong Complex with Symmetric Architecture 118
Small-Molecule Ebselen Binds to YTHDF Proteins Interfering with the Recognition of N 6-Methyladenosine-Modified RNAs 115
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states 113
Inhibitory Properties of ATP-Competitive Coumestrol and Boldine Are Correlated to Different Modulations of CK2 Flexibility 108
The Crystal Structure of Human CDK7 and Its Protein Recognition Properties 107
Insight into GFPmut2 pH Dependence by Single Crystal Microspectrophotometry and X-ray Crystallography 106
Molecular architecture of the glycogen- committed PP1/PTG holoenzyme 105
Binding to DNA of the RNA-polymerase II C-Terminal Domain allows discrimination between Cdk7 ad Cdk9 phosphorylation 100
Reevaluation of bromodomain ligands targeting BAZ2A 88
Inhibitor affinity chromatography: Profiling the specific reactivity of the proteome with immobilized molecules 87
Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing 86
PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability 79
Structural Determinants of Protein Kinase CK2 Regulation by Autoinhibitory Polymerization 74
Enhanced cellular death in liver and breast cancer cells by dual BET/BRPF1 inhibitors 72
Recognition of Cdk2 by Cdk7 70
New directions for CDKs and HDACs inhibition in cancer therapy 66
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer 66
Structure and single crystal spectroscopy of Green Fluorescent Proteins 62
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation 62
Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2 58
Mapping cryptic phosphorylation sites in the human proteome 53
Structural dissection of cyclin dependent kinases regulation and protein recognition properties 53
The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2 52
Structural and functional determinants of protein kinase CK2 alpha: facts and open questions 49
Switching off CK2-mediated activation of survivin offers new therapeutic opportunities in neuroblastoma 15
Protein glycosylation and synaptic transmission: brain glycogen keeps them separated 15
Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient 10
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort 10
Totale 6.136
Categoria #
all - tutte 28.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.011
Totale 29.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 0 0 0 0 94 62 32
2021/2022678 51 68 3 20 61 28 15 182 37 81 40 92
2022/2023698 94 78 6 106 67 118 1 65 108 16 26 13
2023/2024317 22 33 47 11 32 65 12 19 2 19 8 47
2024/20251.177 18 23 64 222 78 153 38 29 140 256 97 59
2025/20261.928 138 51 222 305 220 193 367 64 180 188 0 0
Totale 6.136